chronic liver disease
Conditions
Interventions
Sobriety Diary entry on the Sobriety Line bot
Sponsors
Kansai Medical University
Science and Technology, Nara Institute of Science and Technology (NAIST)
Division of Drug Informatics, Keio University Faculty of Pharmacy
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients with hepatic disease attending or hospitalized at the Department of Gastroenterology and Hepatology, KMU Medical Center, or the Department of Gastroenterology and Hepatology, Kansai Medical University Hospital. 2) Patients who are 20 years of age or older at the time of consent (regardless of gender). 3) Patients with a history of heavy drinking of alcohol. Heavy alcohol drinkers are defined here as those who drink in amounts that increase the risk of lifestyle-related diseases (net alcohol intake of 40 g or more per day for men and 20 g or more per day for women). 4) Those who have an AUDIT score of 8 or higher. 5) Those whose physician has determined that abstinence from alcohol or sobriety is necessary as treatment. 6) Those who have agreed to our sobriety intervention regarding abstinence from alcohol or sobriety. 7) Those who have received a thorough explanation of their participation in this study, and who have given written consent of their own free will based on a thorough understanding of the situation. 8) Those who have a smart phone with a LINE account.
Exclusion criteria
Exclusion criteria: 1) Patients who are unwilling to abstain from alcohol or to sobriety 2) Patients who fail to comply with hospital admissions and outpatient visits 3) Patients who refuse sobriety interventions 4) Patients with severe mental illness other than alcohol use disorder 5) Patients who have already been diagnosed with dementia 6) Patients who have been sober for more than one year 7) Other patients deemed inappropriate as research subjects by the principal investigator 8) Patients who cannot consent to the use of the experimental specification communication application (LINE) on their smart phones
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of the accuracy of AI summary statements based on sobriety LINEbot input. | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of the accuracy of AI summary statements based on sobriety LINEbot input. 1) Weekly alcohol intake (alcohol equivalents/week) before and after 12 weeks of using the abstinence LINE bot. 2) Number of participants who remained abstinent from alcohol during the participation period / number of participants 3) Number of participants who reduced their alcohol intake by 33% or more before and after the participation period / number of participants 4) Percentage of participants who used the abstinence LINE bot (number of days abstinence LINE bot was used/number of follow-up days) 5) Whether or not the use of the abstinence LINE bot reduced the burden of medical care (questionnaire to examining physicians, VAS display) 6) Descriptive evaluation of medication compliance status if medication status is included in the summary statement. 7) Conduct a survey on the user experience of the LINE chatbot to contribute to functional improvements. | — |
Countries
Japan
Contacts
Public ContactNoriyo Yamashiki
Kansai Medical University Department of Gastroenterology and Hepatology
Outcome results
None listed